Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Dr. Machiels on Challenges and Ongoing Trials in Head and Neck Cancer

Jean-Pascal Machiels, MD
Published: Monday, Jun 26, 2017



Jean-Pascal Machiels, MD, head of the Department of Medical Oncology, Cliniques Universitaires Sain-Luc, discusses challenges still facing the field of head and neck cancer and ongoing trials with a goal to improve patient outcomes.

There are still many challenges facing the field of head and neck cancer, explains Machiels. Head and neck cancer is mostly induced by tobacco and alcohol use, which adds many comorbidities for these patients.

There are ongoing trials with avelumab (Bavencio) combined with chemoradiation, which can possibly help improve the outcomes for these patients.
 


Jean-Pascal Machiels, MD, head of the Department of Medical Oncology, Cliniques Universitaires Sain-Luc, discusses challenges still facing the field of head and neck cancer and ongoing trials with a goal to improve patient outcomes.

There are still many challenges facing the field of head and neck cancer, explains Machiels. Head and neck cancer is mostly induced by tobacco and alcohol use, which adds many comorbidities for these patients.

There are ongoing trials with avelumab (Bavencio) combined with chemoradiation, which can possibly help improve the outcomes for these patients.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
Publication Bottom Border
Border Publication
x